PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.50%
Negative revenue growth while NEM stands at 26.42%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.30%
Negative gross profit growth while NEM is at 73.94%. Joel Greenblatt would examine cost competitiveness or demand decline.
-5.62%
Negative EBIT growth while NEM is at 144.66%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-5.62%
Negative operating income growth while NEM is at 144.66%. Joel Greenblatt would press for urgent turnaround measures.
-16.06%
Negative net income growth while NEM stands at 119.25%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.00%
Negative EPS growth while NEM is at 119.26%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.11%
Negative diluted EPS growth while NEM is at 119.26%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.34%
Share count expansion well above NEM's 0.22%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.70%
Diluted share count expanding well above NEM's 0.44%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-2.65%
Negative OCF growth while NEM is at 189.53%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-2.65%
Negative FCF growth while NEM is at 111.01%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
141.24%
10Y revenue/share CAGR above 1.5x NEM's 46.05%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
124.47%
5Y revenue/share CAGR 1.25-1.5x NEM's 100.70%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
40.43%
Below 50% of NEM's 99.86%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-7.79%
Negative 3Y OCF/share CAGR while NEM stands at 34.50%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
622.91%
Below 50% of NEM's 1366.99%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
229.95%
3Y net income/share CAGR 1.25-1.5x NEM's 201.62%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
874.54%
10Y equity/share CAGR above 1.5x NEM's 66.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
1188.92%
5Y equity/share CAGR above 1.5x NEM's 26.05%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-88.33%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.81%
Firm’s AR is declining while NEM shows 36.34%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
60.34%
Asset growth above 1.5x NEM's 8.10%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.70%
Under 50% of NEM's 5.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.06%
We cut SG&A while NEM invests at 38.89%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.